The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
Please note that the account you create here is different than your Keystone Symposia account at www.keystonesymposia.org used to register for our multi-day conferences and is uniquely for viewing our virtual content.
Taking Science‑Based Solutions to Scale
Free
Standard Price
This product is also available as part of the following products:
Tuberculosis: Science Aimed at Ending the Epidemic
December 2-4, 2020 | 10:00AM EST | 3:00PM UTC
The aim of this symposium is to mobilize the rigor, creativity and forward-momentum of scientists worldwide to discover and develop new tools that will end the TB epidemic. A few unique features of this conference include sessions that will explore advances across the ecosystem from early discovery through translation and real-world application, as well as sessions that address scientific bottlenecks to be overcome in the search for new tools to prevent, diagnose and definitively cure TB. Finally, the conference will include sessions dedicated to lessons learned from leprosy. There will be numerous opportunities for scientists to catalyze scientific advances that address the global burden of TB.
#VKSTBepidemic21
Free Access to On Demand Content to Scientists from Low-and Middle-Income Countries
Keystone Symposia welcomes the global scientific community and aims to connect researchers within and across disciplines to accelerate the advancement of biomedical and life sciences. This form may be used for scientists from low- and middle-income countries of all career stages to determine eligibility and request free access to scientific content presented during recent eSymposia events. If eligible, you will be sent an access code for the On Demand content of the eSymposia event(s) of interest.
This ePanel will celebrate the inaugural winners of the Michelson Philanthropies & Science Prize for Immunology, an international prize that focuses on transformative research in human immunology, with trans-disease applications to accelerate vaccine and immunotherapeutic discovery…
B cells contribute to multiple aspects of autoimmune disorders through autoantibody production, antigen presentation, cytokine secretion, and formation of tertiary lymphoid structures. B cell targeting therapies have been developed and approved for treatment of autoimmune diseases…
Genome-wide association studies have identified genes modulating microglia and inflammation to be associated with an enhanced risk for Alzheimer’s disease (AD). Furthermore, increased microglial activation has been associated with the progression of AD…
Neural mechanism underlying the anti-nausea effect of GIP
Privacy Policy Update: We value your privacy and want you to understand how your information is being used. To make sure you have current and accurate information about this sites privacy practices please visit the privacy center by clicking here.